Session Details

[28P-pm]Metal toxicology/ Air pollution

Fri. Mar 28, 2025 1:30 PM - 5:00 PM JST
Fri. Mar 28, 2025 4:30 AM - 8:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])

[28P-pm336S]Investigation of safety and drug interaction of alumina-modified silica nano-particles

○Wakana Ishizaka1, Haruna Kasai1, Tathuya Asano1, Hiromi Saito1, Kathuhiro Isoda1 (1. Teikyo heisei Univ.)

[28P-pm337]Microbial contamination levels due to differences in the placement and usage of disinfectant bottles installed for COVID-19 countermeasures

○Jun Kobayashi1, Nene Tadokoro1, Nayumi Ohta1, Keiichi Ikeda2 (1. Fac. Nut., Univ. Kochi, 2. Fac. Pharm. Sci., Hokuriku Univ.)

[28P-pm338]Study on the identification of temporary emission sources of volatile organic compounds in indoor air

○Naohiro Oshima1, Shinobu Sakai1, Nahoko Uchiyama1 (1. Nat. Inst. Health Sci.)

[28P-pm339]γ-glutamylcysteine, a glutathione precursor, exhibits higher thiol reactivity for complex formation with iron (III) ions compared to glutathione

○Ryotaro Tsutsumi1, Takuya Yamashita1, Misa Muraoka2, Kazumasa Hirata1,2, Kazuya Nagano1 (1. Sch. Pharm. Sci., Wakayama Medical Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ.)

[28P-pm340]Concentration distribution of perfluorinated carboxylic acids in recycled plastic pellets

Daiki Miyakawa1, Yukana Nagahama1, Mami Miyashita1, Natsuko Kajiwara2, Takayuki Koga1, Yuko Kobuke1, Fumio Soeda1, ○Yukiko Fujii1 (1. Daiichi Univ. Pharm., 2. National Institute for Environmental Studies (NIES))

[28P-pm341S]Period 3 alleviated chronic cadmium exposure-induced nephrotoxicity in mice

○Fumina Susaki1, Kohei Matsushita2, Satoshi Yokota2, Kinya Ohta3, Tomohiro Yamaguchi3, Tatsuya Hasegawa4, Nobuaki Matsui1, Naoki Inagaki1, Tohru Maeda3, Nobuhiko Miura5, Hiroki Yoshioka1,3,6 (1. Department of pharmacy, Gifu University of Medical Science, 2. National Institute of Health Sciences, 3. Department of pharmacy, Kinjo Gakuin University, 4. Department of Environmental Biochemistry, Mount Fuji Research Institute, 5. Department of Health Science, Yokohama University of Pharmacy, 6. Department of Hygiene, Kitasato University School of Medicine)

[28P-pm342]Metabolomics analysis against cisplatin-induced nephrotoxicity

○Hiroki Yoshioka1,2,3, Aya Ogata1, Satoshi Yokota4, Masahiro Sugimoto5, Nobuhiko Miura6, Tohru Maeda2 (1. Department of pharmacy, Gifu University of Medical Science, 2. Department of pharmacy, Kinjo Gakuin University, 3. Department of Hygiene, Kitasato University School of Medicine, 4. National Institute of Health Sciences, 5. Institute for Advanced Biosciences, Keio University, 6. Department of Health Science, Yokohama University of Pharmacy)

[28P-pm343S]Effect of arsenite on cytokines IL-2 and IL-12 involved in the activation of natural killer cells

○Kotone Sumitomo1, Ayako Nakayama1, Hitomi Fujishiro1, Daigo Sumi1 (1. Tokushima Bunri Univ.)

[28P-pm344]Evaluation of oxidative damage of DNA by quinone detected in atmosphere

○Yumi Abiko1, Keigo Matsuda1, Sakura Yoshida1, Akira Toriba1 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ.)

[28P-pm345S]Investigation of toxic cell injury for iron citrate compounds in the human intestinal cell line Caco-2

○Haruki Shirai1, Reona Tsuyukubo1, Yuika Mita1, Mako Sato1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm.Sci.,IUHW.)

[28P-pm346S]Involvement of oxidative stress in cytotoxicity by iron citrate compounds

○Yuika Mita1, Reona Tsuyukubo1, Haruki Shirai1, Mako Sato1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)

[28P-pm347S]Investigation of chemical property of iron citrate compounds in aqueous vehicles using pharmaceutical formulations

○Mako Sato1, Yuika Mita1, Haruki Shirai1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)

[28P-pm348S]Evaluation of Microbial Detectability with the Commercially Prepared Medium for the Sterility Test

○Haruto Yoshida1, Katsuhiko Hayashi2, Sanae Kurakado1, Takahiro Ohnishi2, Kenji Ohya2 (1. Meiji Pharm.Univ., 2. NIHS)

[28P-pm349]Effects of estradiol on the neurotoxicity induced by perfluorooctanoic acid (PFOA)

○Masahiro Kawahara1, Ken-ichiro Tanaka1, Midori Negishi1 (1. Musashino Univ.)

[28P-pm350S]Metabolism of arsenic in anaerobically cultured gut microbes

○Kemmu Matsuhashi1, Yasumitsu Ogra2 (1. Grad. Sch. Med. Pharm. Sci, Chiba Univ., 2. Grad. Sch. Pharm. Sci, Chiba Univ.)

[28P-pm351S]Oleanolic acid prevents PM2.5-induced lung injury via increasing antioxidant factors

○Moeka Shimada1, Rioko Funayama1, Aeri Toratani1, Reno Kinoshita1, Mikako Shimoda1, Masahiro Kawahara1,2, Susumu Hama1,2, Ken-ichiro Tanaka1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Ins. Pharm. Sci., Musashino Univ.)

[28P-pm352S]Study on PFAS exposure in indoor air

○Aika Shinoda1, Yuki Kawai1, Haruka Kamegai1, Akira Aoki1, Yoshinori Okamoto1, Shinobu Sakai2, Hideto Jinno1 (1. Meijo University, 2. National Institute of Health Sciences)

[28P-pm353]Metal transport activity of a mercury transporter double recombinant strains

○Yuka Ohshiro1, Shimpei Uraguchi1, Ryosuke Nakamura1, Yasukazu Takanezawa1, Masako Kiyono1 (1. Sch. Pharm., Kitasato Univ.)

[28P-pm354S]Mercury transport activity of Mer transporter high expressing strains

○AiMaria Matsuda1, Yuka Ohshiro1, Shimpei Uraguchi1, Ryosuke Nakamura1, Yasukazu Takanezawa1, Masako Kiyono1 (1. Sch. Pharm., Kitasato Univ.)

[28P-pm355]Changes in the state of trivalent thallium in solution and its effect on toxicity of hypothalamic neuronal cell line (GT1–7 cells)

○MIZUNO DAI1, Keiko Konoha-Mizuno1, Terumansa Ogawara1, Hama Ryouji1, Masahiro Kawahara2 (1. Faculty of Medicine, Yamagata University, 2. Faculty of Pharmacy, Musashino University)

[28P-pm356]In silico evaluation of human TRPA1 activation by fragrance components contained in fabric softeners

○Yuka Suzuki1, Yoko Mori2, Ryuto Yuasa3, Susumu Ohkawara1, Yasuyuki Kitagawa1, Noriyuki Hatae1, Takashi Isobe1, Nobumitsu Hanioka1, Hideto Jinno3, Toshiko Tanaka-Kagawa1 (1. Yokohama Univ. Pharmacy, 2. Natl. Inst. Health. Sci., 3. Facul. Pharm., Meijo Univ.)

[28P-pm357]In silico evaluation of molecular interactions between human TRPA1 and essential oil components used in medical aromatherapy

○Shino Ogawa1, Yoko Mori2, Ryuto Yuasa3, Susumu Ohkawara1, Yasuyuki Kitagawa1, Noriyuki Hatae1, Takashi Isobe1, Nobumitsu Hanioka1, Hideto 透人3, Toshiko Tanaka-Kagawa1 (1. Yokohama Univ. Pharmacy, 2. Natl. Inst. Health. Sci., 3. Facul. Pharm. Meijo Univ.)

[28P-pm358]In silico evaluation of human TRPA1 activation by organophosphate flame retardants

○Kano Hirota1, Yoko Mori2, Ryuto Yuasa3, Susumu Ohkawara1, Yasuyuki Kitagawa1, Noriyuki Hatae1, Takashi Isobe1, Nobumitsu Hanioka1, Hideto Jinno3, Toshiko Tanaka-Kagawa1 (1. Yokohama Univ. Pharmacy, 2. Natl. Inst. Health. Sci., 3. Facul. Pharm., Meijo Univ.)

[28P-pm359S]Comparison of concentrations of hydroquinones and benzoquinones in the mainstream smoke of heated tobacco products.

○Haruki Tara1, Sakura Yoshida2, Yumi Abiko2, Kanae Bekki3, Yohei Inaba3, Akira Toriba2 (1. Sch. Pharm. Sci., Nagasaki Univ., 2. Grad. Sch. Biomed. Sci., Nagasaki Univ., 3. National Institute of Public Health)

[28P-pm360]Effect of combined exposure to toxic metals on methylmercury cytotoxicity

○yasukazu takanezawa1, Narumi Suda1, Nyu Orimo1, Ryosuke Nakamura1, Yuka Ohshiro1, Shimpei Uraguchi1, Masako Kiyono1 (1. Sch. of Pharm. Kitasato University)

[28P-pm361S]Effect of methylmercury on MRP expression in fatty liver model cells

○Rei Tsunoda1, Yasukazu Takanezawa1, Ryosuke Nakamura1, Yuka Ohshiro1, Shimpei Uraguchi1, Masako Kiyono1 (1. Sch. Pharm., Kitasato Univ.)

[28P-pm362S]Role of p62 in methylmercury emissions

○Ikumi Ohashi1, Ryosuke Nakamura1, Yasukazu Takanezawa1, Yuka Ohshiro1, Shimpei Uraguchi1, Masako Kiyono1 (1. Sch. Pharm., Kitasato Univ.)

[28P-pm363]Effect of methylmercury on nonalcoholic fatty liver disease

○Ryosuke Nakamura1, Ikumi Ohashi1, Yasukazu Takanezawa1, Yuka Ohshiro1, Shimpei Uraguchi1, Masako Kiyono1 (1. Sch. Pharm., Kitasato Univ.)

[28P-pm364]Analysis of polycyclic aromatic hydrocarbons in fine particulate matters derived from automobile exhaust

Ayaka Furukawa1, Yaowatat Boongla2, Thaneeya Chetiyanukornkul3, Sakura Yoshida1, Yumi Abiko1, ○Akira Toriba1 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ., 2. Faculty Sci. Technol., Thamasat Univ., 3. Faculty Sci., Chiang Mai Univ.)

[28P-pm365S]Evaluation of oxidation potential of fine particulate matter derived from indoor biomass combustion

○Hiroki Matsushita1, Yaowatat Boongla2, Thaneeya Chetiyanukornkul3, Sakura Yoshida4, Yumi Abiko4, Akira Toriba4 (1. Nagasaki University Faculty of Pharmaceutical Sciences, 2. Facility Sci. Technol., Thamasat Univ., 3. Facility Sci., Chiang Mai Univ., 4. Graduate School of Biochemical Sciences, Nagasaki University)

[28P-pm366]Analysis of Regional Variation Characteristics of Tropospheric Ozone Using AutoEncoders

○Satoshi Fukushima1 (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ.)

[28P-pm367]Analysis of PM2.5 adherents suppressing Foxp3 expression in human T cell line

○Makoto Osabe1, Tsuyoshi Murahashi1, Toshiyuki Higuchi1 (1. Nihon Pharm. Univ.)

[28P-pm368S]In vitro evaluation on the safety and anti-pollution effect of Clitoria ternatea L. flower extracts in keratinocytes

○Hsuan Fu1, Chun-Yin Yang2, Feng-Lin Yen3 (1. Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University., 2. Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University., 3. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University.)

[28P-pm369S]The water solubility, skin permeability, antipollution activity of luteolin nanofibers

○Si-Ting Chen1, Tzu-Hui Wu2, Feng-Lin Yen1, Hsuan Fu3 (1. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80756, Taiwan., 2. Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, Pingtung 90741, Taiwan., 3. Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.)

[28P-pm370][Withdrawn]

[28P-pm371S]Effects of environmental chemical exposure on enzyme function via chemical modification of enterobacterial proteins

○Rika Imai1,4, Kohsuke Sugiyama2, Kensuke Sato3, Hanako Aoki1,3, Jun Uchiyama3,4, Ryota Nakano1, Maiko Kusano2, Hitoshi Kawazoe4,5, Hisakazu Ohtani4,5, Noriko Hida1, Masahiro Akiyama3 (1. Showa Univ. Fac. Pharm., 2. Showa Univ. Sch. Med., 3. Showa Univ. Clin. Res. Inst., 4. Keio Univ. Fac. Pharm., 5. Keio Univ. Sch. Med.)

[28P-pm372S]In vitro anti-PM and cosmetic dosage form development of Compound A on human keratinocytes

○Yu-Hsuan Su1, Tzu-Hui Wu2, Pamela Berilyn So1, Feng-Lin Yen1, Hsuan Fu3 (1. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, 2. Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, 3. Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University)

[28P-pm373S]Application of biosurfactant sophorose lipid from yeast Starmerella bombicola enhances the hair growth effect of minoxidil without the inflammation

○Ayana Mizuno1, Ryotaro Tsutsumi1, Yuki Miyazaki1, Erika Kunimi2, Kazumasa Hirata1,2, Masako Nakanishi3, Shogo Ehata3, Takuya Yamashita1, Kazuya Nagano1 (1. Sch. Pharm. Sci., Wakayama Medical Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Sch. Med., Wakayama Medical Univ.)

[28P-pm374]Study of pollen concentration collected with Burkard sampler in Sapporo, 2024

○Koki Hirashima1, Shinji Takeuchi1 (1. Hokkaido Inst. Public Health)

[28P-pm375S]Screening of driver adduct of halogenated hydrocarbons, a causative agent of occupational cholangiocarcinoma

○Shuhei Shiratori1, Koichi Kato1, Jun'ichi Nakajima1, Masami Komiya1, Min Gi3, Shugo Suzuki3, Hideki Wanibuchi3, Zavadil Jiri4, Kohei Watanabe1, Yukari Totsuka2 (1. Sch. Pharm, Nihon Univ., 2. Hoshi Univ., 3. Grad. Sch. Medicine, Osaka Metropolitan Univ., 4. International Agency for Research on Cancer (IARC))

[28P-pm376S]Exploration of driver adducts and elucidation of mutagenesis mechanisms in alcohol-related carcinogenesis

○Mina Motohashi1, Takeji Takamura2, Akira Sassa3, Koichi Kato1, Junichi Nakajima1, Yukari Totsuka4 (1. School of Pharmacy, Nihon University, 2. Kanagawa Institute of Technology, 3. Graduate school of Science, Chiba University, 4. Hoshi University)

[28P-pm377]Genotoxicity assessment of bicyclic aromatic amines

○Kohei Watanabe1, Kohei Shimomura1, Ayaka Ando1, Reika Sato1, Chisaki Suzuki1, Madoka Takeuchi1, Noriyuki Miyoshi2, Takuma Kobayashi2, Jun’ichi Nakajima1, Koichi Kato1, Yukari Totsuka3 (1. Sch. Pharm. Nihon Univ. , 2. Sch. Food and Nutr. Sci. Univ. Shizuoka, 3. Sch. Pharm. Hoshi Univ.)

[28P-pm378S]Assessment of the impact of vancomycin-induced acute kidney injury on 30-day in-hospital mortality, length of stay and healthcare costs: a study using MDV practice data.

○Sayuri Otogawa1, Shutaro Murakami1,2, Kotona Hirose1, Azusa Ishiyama1, Koga Miyahara1, Ryoko Sakai1, Manabu Akazawa 1 (1. Meiji pharmaceutical University, 2. Tokyo Metropolitan Tama Medical Center)

[28P-pm379]Significance of the revised cannabis control act: prevention of cannabis abuse and medical applications

○Masahiko Funada1,2, Daigo Ikegami1, Kenichi Tomiyama2 (1. Shonan University of Medical Sciences, 2. National Center of Neurology and Psychiatry)

[28P-pm380]Study on a method for predicting the developmental neurotoxicity of CBD using human iPS cells

○Koshiro Sogawa1, Ryuichiro Hosoya1, Daigo Ikegami1, Hideaki Kato1, Masahiko Funada1 (1. Shonan University of Medical Sciences)